Equity Details
Price & Market Data
Price: $59.00
Daily Change: +$19.44 / 32.95%
Daily Range: $39.56 - $59.00
Market Cap: $2,922,907,768
Daily Volume: 100
Performance Metrics
1 Week: 21.40%
1 Month: 21.40%
3 Months: 49.14%
6 Months: 49.14%
1 Year: 49.14%
YTD: 21.40%
About Dermapharm Holding SE (DMPHF)
Summarized market data for Dermapharm Holding SE (DMPHF). Price: 59.00, daily change: +$19.44 / 32.95%. Market cap: 2,922,907,768. Performance over 3-month and 6-month periods.
Company Details
Employees: 3500
Sector: Health technology
Industry: Pharmaceuticals: major
Country: Germany
Details
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands. The company was founded in 1991 and is headquartered in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.